Milken Institute
Showing 691–705 of 2094 transcripts.
- 1h 0m
The Business Case for Addressing Social Determinants of Health
Joanne Kenen, Georges Benjamin, Thomas Moriarty, Ashley Perry, Lauren Shweder Biel, Emily Yu, Joanne Cannon, Lauren Schwader-Beal, Catherine Connolly, Michael Golinkoff
A panel of public health leaders and industry executives from organizations including DC Greens, CVS, and Socially Determined defined social determinants of health as critical external factors like housing and food security that drive clinical outcomes. The discussion highlighted actionable case studies, such as DC Greens' Produce Rx program and CVS's expansion of health hubs, which utilize data analytics to prove return on investment and shift SDOH interventions from philanthropic pilots to core business strategies. Participants emphasized that future success requires multisector coalitions to move beyond simple referrals toward shared accountability models that address systemic root causes while leveraging new value-based care incentives.
- 48 min
Building the Mental Health System We Need
Robert Wilkie, Freda Lewis-Hall, Kay Jamison, Ronald Kessler, Robert Nelsen, Richard Pops, Brandon Staglin, Ron Kessler, Bob Nelson, Shawmi Finless
Current mental health systems struggle with diagnostic ambiguity and payment barriers that leave one in five Americans untreated, resulting in premature mortality and a $3 trillion global economic burden. To address these systemic failures, experts propose shifting from subjective symptom scales to a data-driven framework utilizing passive monitoring and quantitative biomarkers for early, personalized intervention. This approach aims to expand access to Coordinated Specialty Care, accelerate drug approval through regulatory reform, and integrate workforce innovations to break the cycle of chronic disease and incarceration.
- 1h 0m
The Power of Place-Based Philanthropy
Diana Bucco, Cindy L. Citrone, Shirley Franklin, Wes Moore, La June Montgomery Tabron
Five institutional and personal philanthropy leaders, including Diana Bucco, Lejeune Callison-Montgomery-Tabron, Wes Moore, Shirley Franklin, and Cindy Citrone, convened to define place-based strategies that anchor resources within specific geographies to address systemic issues like poverty and racism. The panel highlighted measurable outcomes such as reducing veterans homelessness in New York to near zero and transforming a lowest-performing Atlanta school into a top-five district institution through holistic, long-term community investment. By prioritizing local governance, generational commitments, and the "Series A" role of de-risking innovations for eventual government adoption, these leaders aim to shift philanthropy from reactive grant-making to sustainable, neighborhood-scale transformation.
- 54 min
Gun Violence as a Public Health Crisis
Edward Greissing, Dan Diamond, Megan L. Ranney, Babak Sarani, Leana Wen, Mallory Williams, Chris Corey, Josh Wright, Hazelwood
A diverse panel of medical experts and advocates asserts that while gun violence is increasingly recognized as a public health epidemic, federal research funding remains critically stagnant due to the 1996 Dickey Amendment, leaving survivors of mass shootings without verified data tracking. Consequently, the group advocates for shifting focus from sweeping federal bans on assault rifles to localized, holistic interventions such as Baltimore's "Safe Streets" violence interruption model and evidence-based policies targeting high-capacity magazines and domestic violence. Looking forward, the panel predicts that systemic change will likely emerge from private sector risk incentives and upstream socioeconomic investments rather than immediate national legislative breakthroughs.
- 42 min
Walking the Drug-Pricing Tightrope: Fostering Innovation While Maintaining Affordability
Dan Diamond, Matthew Eyles, Dan Leonard, Mark McClellan, Seema Verma, Greg Walden, Matt Iles
Moderated by Dan Diamond, a panel comprising Seema Verma, Matt Iles, Dan Leonard, and Mark McClellan examined the unsustainability of U.S. drug spending and the urgent need for bipartisan legislation to address the "gross-to-net" price bubble and the rising cost of ultra-high therapies. While the group agreed that current payment models create perverse incentives for manufacturers of legacy drugs and antimicrobials, they diverged on solutions, with CMS advocating for private sector competition and industry representatives emphasizing the risks of government price-setting on research and development. The discussion concluded that structural reforms, including value-based arrangements and targeted regulatory changes to Medicaid Best Price rules, are essential to align reimbursement with modern cure cycles before the projected 2026 spending crisis forces administrative intervention.
- 58 min
Age-Forward 2030: The Intersection of Housing and Health Care
Susan Donley, Gretchen Alkema, Bechara Choucair, Tama Duffy Day, Christopher Herbert
A comprehensive panel convened by AARP, city health officials, and healthcare leaders identified housing as the critical determinant of health outcomes for seniors, highlighting that over half of middle-income older adults cannot afford to age in place. The discussion detailed how structural inequities, rising housing costs, and social isolation drive severe disparities in mortality and medical expenses, while showcasing innovative solutions like California's Master Plan for Aging and shared housing models that integrate care directly into residential communities. To achieve a future where 16 million elderly households can remain safely housed, the group advocated for bipartisan federal infrastructure investments, inclusive zoning reforms, and a systemic shift toward embedding social health and accessibility into Medicare benefits by 2030.
- 59 min
Reducing the Cost of Antimicrobial Resistance
Allan Coukell, Ella Balasa, Nick Crabb, Mark Feinberg, Jeremy Knox, Jenelle Krishnamoorthy, Alan Kockel, John Rigg, Robert Horn
This event convened global health experts to address the critical economic barriers and market failures preventing the development of new antimicrobials amidst rising resistance. Panelists highlighted the urgent need for innovative pull incentives, such as the UK's subscription model, to replace volume-based revenue while emphasizing that stewardship and rapid diagnostics are essential to preserve drug efficacy. The consensus called for immediate policy action to align public, private, and philanthropic resources across G20 nations to sustain the antibiotic innovation ecosystem before the window of opportunity closes.
- 57 min
Sexual, Reproductive, and Maternal Health in America
Meg Tirrell, Michael Lu, Christy Turlington Burns, Lauren Underwood, Leana Wen
With over 700 U.S. women dying annually from pregnancy-related causes and stark racial disparities driving these statistics, Representative Lauren Underwood established the bipartisan Black Maternal Health Caucus to mobilize legislative action and secure federal funding for research. This caucus is advancing critical reforms including extending Medicaid postpartum coverage to 12 months, mandating implicit bias training for accredited providers, and scaling safety bundle protocols that have previously reduced maternal mortality by 60%. Addressing systemic barriers such as over-medicalization and social determinants, the initiative seeks to replace the archaic six-week checkup model with continuous care and technology integration to treat maternal health with the urgency of other major public health crises.
- 59 min
Advancing Global Health Equity Through the SDGs
Thomas Bollyky, Ruth Berg, Patrick Fine, Melissa J. Kopolow McCall, Tom Boyke, Katherine Connelly
The discussion highlights the 2015 UN Sustainable Development Goals' structural shift toward integrated, cross-sectoral approaches led by entities like AB InBev, Palladium, and FHI 360 to address gaps in child mortality and non-communicable disease outcomes. Participants debate the necessary evolution from primary health care to universal health care, emphasizing the critical roles of private sector financing, data disaggregation, and new donors from China and India in achieving a "leave no one behind" framework. Ultimately, the dialogue underscores the ethical complexities of engaging industry leaders in public health strategies while advocating for local ownership, fiscal policy reforms, and stakeholder capitalism to drive measurable, sustainable results.
- 56 min
Resilient Communities, Successful Disaster Recovery
Lynn Goldman, Elizabeth Disco-Shearer, Nancy Knight, Robert Ottenhoff, Umair A. Shah, John Balbus
This panel unites CDC officials, Harris County Public Health leaders, and philanthropic experts to address the critical "invisibility crisis" where preventative public health work remains unrecognized until disasters strike. Drawing on funding allocations like the CDC's $620 million in emergency preparedness and the disproportionate 10% of philanthropic dollars given to mitigation, the speakers argue that the current reactive funding model fails to address long-term health and economic vulnerabilities exposed by events such as the 2024 California wildfires. To counter these systemic gaps, the discussion calls for a strategic shift toward human capital resilience and sustained investment in pre-existing social vulnerabilities to ensure communities can withstand climate-driven extremes.
- 58 min
Poised to Break the Bank: Paying for Chronic Disease
Allison Aubrey, Nancy Brown, Thomas Davis, Anand Parekh, Eric, Michael Golinkoff, John Rother, Megan Golden, Jess Leifer, Stephanie Cousins
Geisinger Health's pilot food pharmacy program demonstrated that high-intensity nutritional support significantly lowers chronic disease costs and improves patient outcomes, prompting federal interest through the 2018 Farm Bill despite scalability challenges. While experts advocate for integrated payment models and preventive policies like sugar taxes to address widespread chronic conditions, systemic barriers including data fragmentation, misaligned pharmaceutical incentives, and insufficient medical education continue to hinder broad adoption. Successful scaling now requires multi-payer collaboration to align financial incentives and address interconnected mental health and pain management needs that frequently undermine lifestyle interventions.
- 16 min
A Conversation with Maxine Waters, US Representative, California
The Congressional Task Force on Alzheimer's Disease, led by a Congresswoman whose advocacy is driven by personal family tragedy, has secured bipartisan funding that raised research allocations from $586 million in 2015 to a $2.65 billion request for 2020. This legislative push aims to achieve a cure or effective treatment by 2025 while addressing critical caregiver burdens and correcting public misconceptions about memory loss through expanded testing and outreach to underrepresented populations. With significant support from 130 lawmakers and the private sector, the initiative focuses on drug pricing reforms and integrated medical strategies to prevent the disease from bankrupting the national healthcare system.
- 57 min
Turning Back Time: The Science of Aging
Joanne Kenen, Nir Barzilai, Howard Fillit, Christopher Hite, Joan Mannick, Joanne Cannon, Sami, Aditi Ramdurai, San, Sarah Locke
A panel of experts led by Nir Barzilai, Christopher Healy, Howard Federoff, and Joan Manik is advocating for a paradigm shift in geroscience from treating individual chronic conditions to targeting the underlying biology of aging. The group is pursuing "healthspan compression" through concrete initiatives like the TAME metformin trial, TORC1 inhibitor development, and combination therapies designed to delay multiple diseases simultaneously. While regulatory hurdles and ethical concerns regarding long-term drug use remain, these efforts aim to prove that extending healthy life is economically viable and socially transformative.
- 58 min
Redefining Philanthropic Drug Discovery
Emma Court, Bob Crutchfield, Kathy Giusti, John Rigg, Todd Sherer
Representative non-profits including the Multiple Myeloma Research Foundation, American Cancer Society, and Michael J. Fox Foundation are deploying specialized venture funds and pre-competitive consortia to accelerate drug development through strategic data ownership and direct investment. These entities face significant structural challenges regarding talent acquisition, donor reluctance to forgo financial returns, and the lack of viable reimbursement models for critical areas like antimicrobial stewardship. Panelists recommend that organizations conduct rigorous landscape assessments and adopt neutral, execution-focused investment strategies to bridge the gap between philanthropy and commercial innovation without crowding out private sector growth.
- 35 min
A Conversation with Chef José Andrés, Founder, World Central Kitchen
Founder Jose Andres leads World Central Kitchen in delivering over 10 million meals across multiple continents through an agile, volunteer-driven model that rejects rigid planning in favor of on-the-ground adaptability. The organization addresses critical needs in disaster zones like the Bahamas and Haiti by deploying innovative logistics such as helicopter fleets and clean cooking stoves, while simultaneously supporting economic recovery through local restaurant support and vocational training. Relying almost exclusively on small-dollar donations to maintain operational speed, WCK challenges traditional relief frameworks by prioritizing fresh food, dietary customization, and long-term solutions to global malnutrition and poverty.